FDA SHOWS GENERIC LAMOTRIGINE EXTENDED-RELEASE TABLETS ARE BIOEQUIVALENT TO INNOVATOR DRUG IN FULLY REPLICATED CROSSOVER BIOEQUIVALENCE STUDY

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Source:
    States News Service. July 26, 2023